Latest news
Jiangsu Hengrui discloses 8.9% Kailera Therapeutics (KLRA) stake in ownership filing - Stock TitanStock Titan · Wed, 05 Aug 2026 10:05:24 GMTKailera Therapeutics (KLRA) 10K Form and Latest SEC Filings 2026 - MarketBeatMarketBeat · Wed, 05 Aug 2026 07:00:00 GMTKailera Therapeutics, Inc. Revenue Breakdown – NASDAQ:KLRA - TradingViewTradingView · Tue, 28 Jul 2026 18:07:23 GMT